Greater Occipital Nerve Blockade in Veterans With Post-concussion Headache: Sub-study 1

Part of paid clinical trials in West Haven, Connecticut.

Sponsor
Yale University
Study ID
NCT06069791
Phase
PHASE1
Status
Recruiting

Conditions

  • Post-Traumatic Headache

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Bupivacaine Injection — DRUG
    subcutaneous injection around bilateral greater occipital nerves

Study Details

The acute and subacute sensations that occur on the scalp with injection of different concentrations of bupivacaine for grater occipital nerve blockade will be compared. Each Veteran participant will be randomized to receive three different concentrations, which will be injected one week apart each.

Key Dates

Start date
Jan 26, 2024
Status verified
Jan 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
12 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER

Arms

  • Experimental: Group 1
    bupivacaine 0.0%, 0.01%, and 0.05% in random order, one week apart each
  • Experimental: Group 2
    bupivacaine 0.1%, 0.05%, and 0.1% in random order, one week apart each
  • Experimental: Group 3
    bupivacaine 0.0%, 0.1%, and 0.5% in random order, one week apart each
  • Experimental: Group 4
    bupivacaine \[0.01% or 0.05%\], \[0.05% or 0.1%\], and 0.05% in random order, one week apart each

Primary Outcome Measure

Acute sensation felt during injection: quality [ Time Frame: During injection ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
VA Connecticut Healthcare SystemWest HavenConnecticut06516
Emmanuelle Schindler, MD, PhD
203-932-5711

Find similar trials in West Haven, CT

Related Studies